Type 2 Diabetes - Pipeline Review, H1 2014
Albany, New York (PRWEB) April 10, 2014
Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Type 2 Diabetes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Type 2 Diabetes and special features on late-stage and discontinued projects.
Complete Report With TOC at http://www.researchmoz.us/type-2-diabetes-pipeline-review-h1-2014-report.html.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
All Countrywise Report at http://www.researchmoz.us/country.html.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
The report provides a snapshot of the global therapeutic landscape of Type 2 Diabetes
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Type 2 Diabetes and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects
A review of the Type 2 Diabetes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Type 2 Diabetes pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products
All Latest Market Research Report at http://www.researchmoz.us/latest-report.html.
Reasons to buy
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Type 2 Diabetes
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Devise corrective measures for pipeline projects by understanding Type 2 Diabetes pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Diabetes App Market Report 2014
Diabetes has become a global epidemic (http://www.researchmoz.us/diabetes-app-market-report-2014-report.html) with significant impact on society and the economy. In 2013 around 382M people around the world were estimated to suffer from diabetes. Mobile applications promise to play an invaluable role in assisting people who suffer from diabetes to empower them to better manage their condition and as a consequence reduce health care costs. Mobile apps can aid in the daily management of diabetes by supporting behaviour changes, facilitating communication and easing the hassle of keeping track of all relevant parameters that have an influence on the disease.
Trends and Opportunities in the Diabetes Care Market
This report provides (http://www.researchmoz.us/trends-and-opportunities-in-the-diabetes-care-market-report.html) everything you need to know about the current market for diabetes care devices; from detailed analysis of the products, companies and developments influencing its growth to an in-depth manufacturer directory detailing company movements within the market and key financial data (where available).The global market for diabetes devices was estimated to be worth US$ 12.2 billion in 2012. And although this market was in decline due to intense competition and low reimbursement levels, as well as being traditionally dominated by 6 major manufacturers, good opportunities are growing more apparent for companies with unique diabetes devices or that compete in yet to be established markets.
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis.We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports.We provide our services to all sizes of organizations and across all industry verticals and markets.Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948